Uncategorized
Agenus cancer cocktail records 0% response rate, missing midstage goal
Agenus cancer cocktail records 0% response rate, missing midstage goal
An investigational cocktail was tied to a 0% overall response rate in patients with gastroesophageal cancer, but developers Agenus and MiNK Therapeutics aren’t giving up on the program just yet. Read More